Montanine

ID: ALA1221863

Cas Number: 642-52-4

PubChem CID: 11087935

Max Phase: Preclinical

Molecular Formula: C17H19NO4

Molecular Weight: 301.34

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Synonyms: Montanine | Montanine|642-52-4|(-)-Montanine|Compound NP-016462|SCHEMBL812255|CHEMBL1221863|DTXSID801107687|BDBM50190649|AKOS040738613|(1S,13S,15S,16S)-16-methoxy-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,8.013,18]nonadeca-2,4(8),9,17-tetraen-15-ol|(6R,6aS,8S,9S,11S)-5,6a,7,8,9,11-Hexahydro-9-methoxy-6,11-methano-6H-benzo[b]-1,3-benzodioxolo[5,6-e]azepin-8-ol

Canonical SMILES:  CO[C@H]1C=C2[C@H]3CN(Cc4cc5c(cc43)OCO5)[C@H]2C[C@@H]1O

Standard InChI:  InChI=1S/C17H19NO4/c1-20-15-4-11-12-7-18(13(11)5-14(15)19)6-9-2-16-17(3-10(9)12)22-8-21-16/h2-4,12-15,19H,5-8H2,1H3/t12-,13-,14-,15-/m0/s1

Standard InChI Key:  MKYLOMHWHWEFCT-AJNGGQMLSA-N

Molfile:  

     RDKit          2D

 24 28  0  0  0  0  0  0  0  0999 V2000
   11.7597  -27.0576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7579  -25.3495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0235  -26.6332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0202  -25.7813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2083  -25.5209    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7093  -26.2103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2138  -26.8998    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.9628  -26.9416    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1534  -27.1459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5052  -26.6355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4988  -25.7744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1156  -25.2759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9118  -25.4501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2965  -26.1579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1007  -26.1778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5261  -25.5028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1464  -24.7855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3312  -24.7581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3592  -25.5028    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.5652  -24.0662    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.4080  -24.0662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3166  -26.0370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9223  -24.4645    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   14.7484  -26.8613    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  3  1  1  0
  1 10  2  0
 11  2  2  0
  2  4  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  3  1  0
  8 14  1  0
  8  9  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  9 10  1  0
 13 14  1  0
 13 18  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  1
 17 20  1  6
 20 21  1  0
 12 22  1  0
  8 22  1  0
 12 23  1  6
 14 24  1  1
M  END

Alternative Forms

  1. Parent:

    ALA1221863

    MONTANINE

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Butyrylcholinesterase (7174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ache Acetylcholinesterase (12221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trichomonas vaginalis (2376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 301.34Molecular Weight (Monoisotopic): 301.1314AlogP: 1.40#Rotatable Bonds: 1
Polar Surface Area: 51.16Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.02CX LogP: 0.69CX LogD: -0.02
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.79Np Likeness Score: 2.12

References

1. McNulty J, Nair JJ, Little JR, Brennan JD, Bastida J..  (2010)  Structure-activity studies on acetylcholinesterase inhibition in the lycorine series of Amaryllidaceae alkaloids.,  20  (17): [PMID:20655219] [10.1016/j.bmcl.2010.06.130]
2. Ortiz JE, Pigni NB, Andujar SA, Roitman G, Suvire FD, Enriz RD, Tapia A, Bastida J, Feresin GE..  (2016)  Alkaloids from Hippeastrum argentinum and Their Cholinesterase-Inhibitory Activities: An in Vitro and in Silico Study.,  79  (5): [PMID:27096334] [10.1021/acs.jnatprod.5b00785]
3. Nair JJ, Wilhelm A, Bonnet SL, van Staden J..  (2017)  Antibacterial constituents of the plant family Amaryllidaceae.,  27  (22): [PMID:29033234] [10.1016/j.bmcl.2017.09.052]
4. Nair JJ, van Staden J..  (2019)  Antiprotozoal alkaloid principles of the plant family Amaryllidaceae.,  29  (20): [PMID:31515186] [10.1016/j.bmcl.2019.126642]
5. Maafi N, Pidaný F, Maříková J, Korábečný J, Hulcová D, Kučera T, Schmidt M, Shammari LA, Špulák M, Carmen Catapano M, Mecava M, Prchal L, Kuneš J, Janoušek J, Kohelová E, Jenčo J, Nováková L, Cahlíková L..  (2021)  Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study.,  51  [PMID:34555506] [10.1016/j.bmcl.2021.128374]

Source